We found evidence for an association between genetically-predicted BMI and CAD risk in a multivariable model including both BMI and T2D, suggesting that the mechanistic pathway from GLP1R to CAD risk passes predominantly via BMI rather than T2D. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.